Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 01 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-2.14 Insider Own36.24% Shs Outstand29.44M Perf Week-1.65%
Market Cap813.94M Forward P/E- EPS next Y-0.81 Insider Trans-0.23% Shs Float18.89M Perf Month15.66%
Income-63.51M PEG- EPS next Q-0.30 Inst Own48.06% Short Float / Ratio4.93% / 4.14 Perf Quarter-15.79%
Sales286.41M P/S2.84 EPS this Y-117.10% Inst Trans1.30% Short Interest0.93M Perf Half Y-31.89%
Book/sh41.91 P/B0.66 EPS next Y18.18% ROA-4.60% Target Price31.50 Perf Year-24.26%
Cash/sh15.79 P/C1.74 EPS next 5Y- ROE-5.01% 52W Range23.09 - 44.09 Perf YTD-7.76%
Dividend- P/FCF37.95 EPS past 5Y- ROI-5.01% 52W High-37.70% Beta1.56
Dividend %- Quick Ratio8.95 Sales past 5Y272.11% Gross Margin29.44% 52W Low18.97% ATR0.77
Employees1012 Current Ratio8.95 Sales Q/Q-19.85% Oper. Margin-28.28% RSI (14)56.44 Volatility2.19% 3.23%
OptionableYes Debt/Eq0.01 EPS Q/Q-884.02% Profit Margin-22.17% Rel Volume0.55 Prev Close27.58
ShortableYes LT Debt/Eq0.01 EarningsNov 03 BMO Payout0.00% Avg Volume224.98K Price27.47
Recom2.50 SMA201.80% SMA504.61% SMA200-14.78% Volume124,258 Change-0.40%
Date Action Analyst Rating Change Price Target Change
Dec-08-22Downgrade Piper Sandler Overweight → Neutral $65 → $40
Nov-18-22Initiated Raymond James Outperform $45
Aug-25-22Initiated Credit Suisse Outperform $65
Feb-04-22Resumed Piper Sandler Overweight $80
Aug-05-21Resumed Credit Suisse Underperform $55
Jan-08-21Downgrade Credit Suisse Neutral → Underperform $42 → $40
Nov-24-20Downgrade BTIG Research Buy → Neutral
Aug-20-20Initiated Oppenheimer Outperform $75
May-29-20Initiated BTIG Research Buy $20
Nov-05-19Upgrade Piper Jaffray Neutral → Overweight
Nov-25-23 09:45AM
Nov-14-23 04:30PM
Nov-05-23 09:02AM
Nov-03-23 10:26PM
08:52AM Loading…
Oct-30-23 03:46PM
Oct-25-23 08:00AM
Oct-18-23 09:44AM
Oct-17-23 08:00AM
Aug-05-23 08:56AM
Aug-04-23 10:08PM
07:00AM Loading…
Jul-24-23 04:05PM
Jul-18-23 08:00AM
Jun-21-23 08:00PM
Jun-14-23 11:40AM
Jun-06-23 07:45AM
Jun-05-23 08:30AM
May-23-23 09:53AM
May-18-23 04:05PM
May-08-23 11:15AM
May-05-23 08:15AM
Apr-26-23 08:00PM
04:05PM Loading…
Apr-20-23 04:05PM
Apr-16-23 02:01PM
Apr-14-23 07:13AM
Apr-12-23 09:40AM
Apr-11-23 08:00AM
Mar-27-23 09:40AM
Mar-24-23 03:54PM
Mar-09-23 09:40AM
Mar-04-23 07:50AM
Mar-03-23 11:17AM
Mar-01-23 10:13AM
Feb-28-23 08:25PM
Feb-26-23 09:05AM
Feb-23-23 04:05PM
Feb-14-23 04:05PM
Feb-03-23 05:18AM
Jan-03-23 04:05PM
Dec-15-22 08:11AM
Dec-02-22 12:08PM
Nov-24-22 10:30AM
Nov-17-22 04:05PM
Nov-16-22 06:52AM
Nov-09-22 08:02AM
Nov-07-22 05:55PM
Oct-26-22 07:54AM
Oct-25-22 04:03PM
Oct-20-22 04:03PM
Oct-10-22 11:31AM
Aug-26-22 07:22AM
Aug-25-22 12:10PM
Aug-23-22 02:03PM
Aug-06-22 05:00AM
Aug-05-22 06:30AM
Aug-04-22 07:25PM
Jul-25-22 06:15PM
Jul-19-22 08:00AM
Jul-14-22 06:17PM
Jul-11-22 09:46AM
Jul-05-22 08:00AM
Jun-29-22 06:15PM
Jun-21-22 06:15PM
Jun-19-22 09:06AM
Jun-04-22 08:06AM
May-19-22 07:04AM
May-17-22 11:30AM
May-03-22 11:30PM
Apr-28-22 10:15AM
Apr-27-22 12:05PM
Apr-25-22 06:05PM
Apr-22-22 11:23AM
Apr-18-22 04:05PM
Apr-08-22 07:55AM
Apr-05-22 04:41PM
Mar-18-22 10:23AM
Fulgent Genetics, Inc. is a technology company, which engages in the provision of gene testing and sequencing solutions. It offers genes and panels, known mutation, hereditary cancer, carrier screening, and tumor profiling solutions. The company was founded by Ming Hsieh on May 13, 2016 and is headquartered in El Monte, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Xie JianPresident and COONov 16Sale27.251,61744,065386,903Nov 20 04:30 PM
Kim PaulCFO and TreasurerNov 16Sale27.251,30735,617201,897Nov 20 04:27 PM
Xie JianPresident and COOSep 07Sale31.411,49246,861416,022Sep 11 04:37 PM
Kim PaulCFO and TreasurerSep 07Sale31.411,49246,861214,061Sep 11 04:35 PM
Gao HanlinChief Scientific OfficerSep 07Sale31.411,04132,696912,932Sep 11 04:34 PM
Kim PaulCFO and TreasurerAug 28Sale33.6210,299346,297215,553Aug 30 04:54 PM
Kim PaulCFO and TreasurerAug 17Sale33.881,79860,918225,852Aug 21 04:40 PM
Xie JianPresident and COOAug 17Sale33.881,30744,283417,514Aug 21 04:43 PM
Gao HanlinChief Scientific OfficerAug 17Sale33.8834211,587913,973Aug 21 04:34 PM
Xie JianPresident and COOJun 02Sale40.301,43357,744425,794Jun 06 05:11 PM
Kim PaulCFO and TreasurerJun 02Sale40.301,40356,535228,890Jun 06 05:09 PM
Gao HanlinChief Scientific OfficerJun 02Sale40.301,00040,296914,391Jun 06 05:06 PM
Xie JianPresident and COOMay 17Sale35.461,32046,810427,227May 19 04:23 PM
Kim PaulCFO and TreasurerMay 17Sale35.461,26644,895230,293May 19 04:19 PM
Gao HanlinChief Scientific OfficerMay 17Sale35.4634512,234915,391May 19 04:15 PM